Cvs Health Corporation (CVS)

$58.01

+0.91

(+1.59%)▲

Market is closed - opens 8 PM, 25 Nov 2024
star icon

CVS Health Corp is a healthcare company that operates a retail pharmacy chain and provides a range of healthcare services and products.

Performance

  • $56.66
    $58.01
    $58.01
    downward going graph

    2.33%

    Downside

    Day's Volatility :2.33%

    Upside

    0.0%

    downward going graph
  • $52.71
    $83.25
    $58.01
    downward going graph

    9.14%

    Downside

    52 Weeks Volatility :36.68%

    Upside

    30.32%

    downward going graph

Returns

PeriodCvs Health CorporationSector (Health Care)S&P500
3 Months
-1.11%
-6.9%
6.8%
6 Months
-0.59%
-1.7%
12.1%
1 Year
-17.41%
10.4%
30.6%
3 Years
-38.6%
8.8%
27.0%

Highlights

Market Capitalization
71.5B
Book Value
$59.57
Dividend Share
2.6
Dividend Yield
4.68%
Earnings Per Share (EPS)
3.94
PE Ratio
14.42
PEG Ratio
1.96
Wall Street Target Price
68.375
Profit Margin
1.37%
Operating Margin TTM
1.59%
Return On Assets TTM
2.37%
Return On Equity TTM
6.7%
Revenue TTM
367.2B
Revenue Per Share TTM
290.2
Quarterly Revenue Growth YOY
6.0%
Gross Profit TTM
53.5B
EBITDA
14.1B
Diluted Eps TTM
3.94
Quarterly Earnings Growth YOY
-0.96
EPS Estimate Current Year
5.37
EPS Estimate Next Year
6.46
EPS Estimate Current Quarter
1.51
EPS Estimate Next Quarter
1.65

Analyst Recommendation

Buy
    66%Buy
    33%Hold
    0
    0%Sell
Based on 33 Wall street analysts offering stock ratings for Cvs Health Corporation(by analysts ranked 0 to 5 stars)
Based on 33 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
22
22
22
Hold
11
11
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 17.87%

Current $58.01
Target $68.38

Company Financials

FY18Y/Y Change
Revenue
194.6B
↑ 5.31%
Net Income
-594.0M
↓ 108.97%
Net Profit Margin
-0.31%
↓ 3.89%
FY19Y/Y Change
Revenue
256.8B
↑ 31.96%
Net Income
6.6B
↓ 1216.84%
Net Profit Margin
2.58%
↑ 2.89%
FY20Y/Y Change
Revenue
268.7B
↑ 4.65%
Net Income
7.2B
↑ 8.22%
Net Profit Margin
2.67%
↑ 0.09%
FY21Y/Y Change
Revenue
292.1B
↑ 8.71%
Net Income
8.0B
↑ 11.45%
Net Profit Margin
2.74%
↑ 0.07%
FY22Y/Y Change
Revenue
321.6B
↑ 10.11%
Net Income
4.3B
↓ 46.12%
Net Profit Margin
1.34%
↓ 1.4%
FY23Y/Y Change
Revenue
357.8B
↑ 11.24%
Net Income
8.3B
↑ 93.55%
Net Profit Margin
2.33%
↑ 0.99%
Q2 FY23Q/Q Change
Revenue
88.9B
↑ 4.27%
Net Income
1.9B
↓ 11.0%
Net Profit Margin
2.14%
↓ 0.36%
Q3 FY23Q/Q Change
Revenue
89.5B
↑ 0.64%
Net Income
2.3B
↑ 18.94%
Net Profit Margin
2.53%
↑ 0.39%
Q4 FY23Q/Q Change
Revenue
93.5B
↑ 4.53%
Net Income
2.0B
↓ 9.51%
Net Profit Margin
2.19%
↓ 0.34%
Q1 FY24Q/Q Change
Revenue
88.0B
↓ 5.95%
Net Income
1.1B
↓ 45.6%
Net Profit Margin
1.27%
↓ 0.92%
Q2 FY24Q/Q Change
Revenue
91.3B
↑ 3.8%
Net Income
1.8B
↑ 59.03%
Net Profit Margin
1.94%
↑ 0.67%
Q3 FY24Q/Q Change
Revenue
95.4B
↑ 4.49%
Net Income
87.0M
↓ 95.08%
Net Profit Margin
0.09%
↓ 1.85%
FY18Y/Y Change
Total Assets
196.5B
↑ 106.51%
Total Liabilities
137.9B
↑ 140.12%
FY19Y/Y Change
Total Assets
222.4B
↑ 13.23%
Total Liabilities
158.3B
↑ 14.77%
FY20Y/Y Change
Total Assets
230.7B
↑ 3.72%
Total Liabilities
161.0B
↑ 1.73%
FY21Y/Y Change
Total Assets
233.0B
↑ 0.99%
Total Liabilities
157.6B
↓ 2.11%
FY22Y/Y Change
Total Assets
228.3B
↓ 2.03%
Total Liabilities
157.0B
↓ 0.42%
FY23Y/Y Change
Total Assets
249.7B
↑ 9.4%
Total Liabilities
173.1B
↑ 10.28%
Q2 FY23Q/Q Change
Total Assets
250.1B
↑ 4.49%
Total Liabilities
177.1B
↑ 5.56%
Q3 FY23Q/Q Change
Total Assets
251.3B
↑ 0.49%
Total Liabilities
176.8B
↓ 0.15%
Q4 FY23Q/Q Change
Total Assets
249.7B
↓ 0.63%
Total Liabilities
173.1B
↓ 2.1%
Q1 FY24Q/Q Change
Total Assets
249.7B
↑ 0.01%
Total Liabilities
175.6B
↑ 1.44%
Q2 FY24Q/Q Change
Total Assets
252.5B
↑ 1.1%
Total Liabilities
177.4B
↑ 1.01%
Q3 FY24Q/Q Change
Total Assets
252.4B
↓ 0.02%
Total Liabilities
177.3B
↓ 0.03%
FY18Y/Y Change
Operating Cash Flow
8.9B
↑ 10.72%
Investing Cash Flow
-43.3B
↑ 1376.3%
Financing Cash Flow
36.8B
↓ 645.39%
FY19Y/Y Change
Operating Cash Flow
12.8B
↑ 44.93%
Investing Cash Flow
-3.3B
↓ 92.29%
Financing Cash Flow
-7.9B
↓ 121.32%
FY20Y/Y Change
Operating Cash Flow
15.9B
↑ 23.48%
Investing Cash Flow
-5.5B
↑ 65.74%
Financing Cash Flow
-8.2B
↑ 3.89%
FY21Y/Y Change
Operating Cash Flow
18.3B
↑ 15.13%
Investing Cash Flow
-5.3B
↓ 4.93%
Financing Cash Flow
-11.4B
↑ 39.25%
FY22Y/Y Change
Operating Cash Flow
16.2B
↓ 11.43%
Investing Cash Flow
-5.0B
↓ 4.07%
Financing Cash Flow
-10.5B
↓ 7.4%
Q2 FY23Q/Q Change
Operating Cash Flow
5.9B
↓ 20.57%
Investing Cash Flow
-10.4B
↑ 21.71%
Financing Cash Flow
3.6B
↑ 33.02%
Q3 FY23Q/Q Change
Operating Cash Flow
2.7B
↓ 54.03%
Investing Cash Flow
-19.6B
↑ 89.61%
Financing Cash Flow
-2.7B
↓ 174.38%

Technicals Summary

Sell

Neutral

Buy

Cvs Health Corporation is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cvs Health Corporation
Cvs Health Corporation
0.44%
-0.59%
-17.41%
-38.6%
-24.18%
The Cigna Corp
The Cigna Corp
3.97%
-1.9%
14.48%
56.02%
63.52%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
4.85%
14.6%
9.88%
36.56%
115.83%
Humana Inc.
Humana Inc.
12.73%
-17.08%
-42.65%
-31.61%
-12.57%
Elevance Health, Inc
Elevance Health, Inc
-3.87%
-26.32%
-15.91%
-3.77%
38.3%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cvs Health Corporation
Cvs Health Corporation
14.42
14.42
1.96
5.37
0.07
0.02
0.05
59.57
The Cigna Corp
The Cigna Corp
30.68
30.68
0.77
28.5
0.08
0.03
0.02
150.61
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
39.07
39.07
1.63
27.61
0.15
0.07
0.01
102.42
Humana Inc.
Humana Inc.
25.63
25.63
1.27
16.14
0.08
0.04
0.01
145.88
Elevance Health, Inc
Elevance Health, Inc
14.47
14.47
0.74
33.02
0.16
0.06
0.02
188.74
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cvs Health Corporation
Cvs Health Corporation
Buy
$71.5B
-24.18%
14.42
1.37%
The Cigna Corp
The Cigna Corp
Buy
$90.0B
63.52%
30.68
1.32%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$552.6B
115.83%
39.07
3.64%
Humana Inc.
Humana Inc.
Buy
$35.4B
-12.57%
25.63
1.18%
Elevance Health, Inc
Elevance Health, Inc
Buy
$92.2B
38.3%
14.47
3.69%

Insights on Cvs Health Corporation

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 87.98B → 95.42B (in $), with an average increase of 4.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 1.77B → 87.0M (in $), with an average decrease of 95.1% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 14.5% return, outperforming this stock by 31.9%

  • Vs CI

    In the last 3 years, The Cigna Corp has given 56.0% return, outperforming this stock by 94.6%

Institutional Holdings

  • Vanguard Group Inc

    9.35%

  • BlackRock Inc

    7.96%

  • Dodge & Cox

    5.01%

  • State Street Corp

    4.33%

  • Capital World Investors

    3.83%

  • Morgan Stanley - Brokerage Accounts

    3.63%

Corporate Announcements

  • Cvs Health Corporation Dividends March,2024

    In the quarter ending March,2024. Cvs Health Corporation has declared dividend of $0.67

    Read More

Company Information

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.

Organization
Cvs Health Corporation
Employees
219000
CEO
Mr. Thomas Francis Cowhey
Industry
Retail Trade

FAQs